BIT2 Antibody

What is BIT2 antibody and what specific target does it recognize?

BIT2 antibody is a rabbit-derived polyclonal antibody that specifically targets the BIT2 protein (UniProt Number P38346, Gene ID 852573) in Saccharomyces cerevisiae. The antibody is produced using recombinant Saccharomyces cerevisiae (strain ATCC 204508 / S288c) BIT2 protein as the immunogen . As a polyclonal antibody, it recognizes multiple epitopes on the target protein, which provides robust detection capability across different experimental applications.

The technical specifications of the antibody include:

What are the recommended storage and handling conditions for BIT2 antibody to maintain optimal activity?

For maximum stability and activity retention, BIT2 antibody should be stored at -20°C or -80°C according to manufacturer specifications . Researchers should implement the following methodological practices:

• Upon receipt, aliquot the antibody into smaller working volumes to avoid repeated freeze-thaw cycles, which can degrade antibody quality

• When preparing working dilutions, maintain antibody on ice throughout the procedure

• Use sterile techniques and reagents when handling to prevent microbial contamination

• For short-term storage (1-2 weeks), diluted antibody can be kept at 4°C with appropriate preservatives

• Include protease inhibitors in experimental buffers to prevent degradation during procedures

• Before each use, centrifuge the antibody vial briefly to collect solution at the bottom of the tube

• Record lot numbers and validation data for each antibody batch to track potential batch-to-batch variations

What experimental controls should be included when using BIT2 antibody in research applications?

When designing experiments with BIT2 antibody, a methodologically sound approach requires these controls:

• Positive control: Use the included 200μg antigen (recombinant BIT2 protein) to verify antibody activity and establish detection limits

• Negative control: Apply the provided pre-immune serum to identify any non-specific binding patterns

• Loading control: In Western blot applications, include detection of constitutively expressed proteins (e.g., actin, GAPDH) to normalize target protein levels

• Genetic controls: When available, include BIT2 knockout/knockdown yeast strains to confirm antibody specificity

• Cross-reactivity assessment: Test antibody against closely related yeast species to evaluate specificity boundaries

• Dilution series: Prepare a concentration gradient of yeast lysate to establish detection threshold and linear range

• Secondary-only control: Incubate sample with secondary antibody alone to identify any direct binding of secondary antibody

What is the optimal protocol for using BIT2 antibody in Western blot applications?

A comprehensive Western blotting protocol optimized for BIT2 antibody includes:

• Sample preparation:

  • Extract total protein from yeast cells using glass bead lysis or enzymatic cell wall disruption

  • Include protease inhibitors in extraction buffer to preserve protein integrity

  • Quantify protein concentration using Bradford or BCA assay

• Gel electrophoresis:

  • Load 10-30 μg total protein per lane on 10-12% SDS-PAGE

  • Include positive control (recombinant BIT2 protein) and negative control (pre-immune serum)

• Transfer and blocking:

  • Transfer to PVDF membrane (preferred for yeast proteins) at 100V for 60-90 minutes

  • Block with 5% non-fat milk or 3% BSA in TBST for 1 hour at room temperature

• Antibody incubation:

  • Dilute BIT2 antibody 1:1000 to 1:2000 in blocking buffer

  • Incubate membrane overnight at 4°C with gentle agitation

  • Wash 3× with TBST, 10 minutes each

  • Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000) for 1 hour

  • Wash 3× with TBST, 10 minutes each

• Detection and analysis:

  • Develop using ECL substrate and capture image with appropriate system

  • Quantify band intensity using densitometry software

  • Normalize to loading control for comparative analysis

How can BIT2 antibody be optimized for use in ELISA applications?

For ELISA applications, researchers should implement this methodological approach:

• Direct ELISA protocol:

  • Coat 96-well plates with serial dilutions of yeast lysate or recombinant BIT2 protein (0.1-10 μg/ml) in carbonate buffer (pH 9.6)

  • Incubate overnight at 4°C

  • Wash 3× with PBS-T (PBS + 0.05% Tween-20)

  • Block with 2% BSA in PBS-T for 2 hours at room temperature

  • Dilute BIT2 antibody (1:500 to 1:5000) in blocking solution

  • Incubate for 2 hours at room temperature

  • Wash 5× with PBS-T

  • Add HRP-conjugated anti-rabbit secondary antibody (1:5000) and incubate for 1 hour

  • Wash 5× with PBS-T

  • Develop with TMB substrate and measure absorbance at 450nm

• Optimization parameters:

  • Test multiple blocking agents (BSA, casein, non-fat milk) to determine optimal signal-to-noise ratio

  • Create an antibody titration curve to identify optimal concentration

  • Vary incubation times and temperatures to enhance sensitivity

  • Compare different detection systems (colorimetric vs. chemiluminescent)

How does the polyclonal nature of BIT2 antibody influence experimental design compared to potential monoclonal alternatives?

The polyclonal nature of BIT2 antibody offers distinct methodological advantages and limitations that researchers should consider:

Advantages of polyclonal BIT2 antibody:

• Recognizes multiple epitopes, increasing detection probability even if some epitopes are masked or modified

• More tolerant to protein denaturation, making it versatile across different applications

• Generally provides stronger signal due to multiple binding sites per target molecule

• More robust against minor changes in target protein structure or conformation

Limitations compared to potential monoclonal alternatives:

• Batch-to-batch variation requires validation for each new lot

• May exhibit higher background due to diverse antibody populations

• Less specificity for distinguishing between closely related proteins

• Limited reproducibility in quantitative applications requiring precise epitope targeting

Methodological considerations:

• Implement epitope mapping to understand which regions of BIT2 are recognized by the polyclonal mixture

• Consider developing custom monoclonal antibodies for applications requiring absolute specificity

• Use epitope tags (HA, FLAG, etc.) as alternative approaches for detection when high specificity is critical

• When using polyclonal antibody, increase washing stringency to reduce background

How can researchers incorporate BIT2 antibody into advanced yeast protein-protein interaction studies?

BIT2 antibody can be integrated into sophisticated protein interaction studies using these methodological approaches:

• Co-immunoprecipitation (Co-IP):

  • Lyse yeast cells in non-denaturing conditions to preserve protein-protein interactions

  • Couple BIT2 antibody to protein A/G beads or magnetic beads

  • Incubate with lysate to capture BIT2 and associated proteins

  • Wash extensively and elute bound complexes

  • Identify interacting partners by mass spectrometry or Western blotting

• Proximity-dependent biotin identification (BioID):

  • Express BIT2 fused to a promiscuous biotin ligase in yeast

  • Allow biotinylation of proximal proteins

  • Purify biotinylated proteins using streptavidin

  • Verify BIT2 presence using the antibody

  • Identify interaction partners by mass spectrometry

• Proximity ligation assay (PLA):

  • Fix and permeabilize yeast cells

  • Incubate with BIT2 antibody and antibody against potential interacting protein

  • Apply PLA probes with attached oligonucleotides

  • Ligate and amplify DNA when probes are in close proximity

  • Visualize interaction as fluorescent spots

  • Quantify interactions using fluorescence microscopy

• Comparative analysis workflow:

  Technique	Resolution	Throughput	Advantages	Limitations
  Co-IP with BIT2 antibody	Low	Medium	Simple, established	Detects stable interactions only
  BioID with BIT2 fusion	Medium	High	Detects transient interactions	Requires genetic modification
  PLA with BIT2 antibody	High	Low	Single-molecule resolution	Complex protocol, specialized equipment
  Yeast two-hybrid	Low	Very high	No antibody needed	High false positive rate

What strategies can overcome challenges in detecting low-abundance BIT2 protein in complex yeast samples?

For detecting low-abundance BIT2 protein, researchers should consider these methodological approaches:

• Signal amplification techniques:

  • Implement tyramide signal amplification (TSA) to enhance chromogenic or fluorescent signal

  • Use high-sensitivity chemiluminescent substrates with extended exposure times

  • Apply poly-HRP conjugated secondary antibodies for multiplicative signal enhancement

  • Implement immunoprecipitation before Western blotting to concentrate target protein

• Sample preparation optimization:

  • Enrich for relevant subcellular fractions where BIT2 is concentrated

  • Use optimized extraction buffers specifically designed for yeast proteins

  • Implement HPLC or chromatography-based pre-fractionation to reduce sample complexity

  • Apply techniques to remove abundant proteins that may mask low-abundance targets

• Advanced detection systems:

  • Utilize digital imaging systems with cooled CCD cameras for better sensitivity

  • Implement quantitative fluorescence Western blotting with infrared detection

  • Consider automated capillary-based protein detection systems for higher sensitivity

  • Use single-molecule detection approaches for extremely low abundance proteins

• Experimental design considerations:

  • Include biological replicates to confirm reproducibility of low-intensity signals

  • Implement positive controls at known dilutions to establish detection limits

  • Consider using tagged overexpression systems to validate antibody binding characteristics

How can BIT2 antibody be integrated with high-throughput screening approaches for yeast functional genomics?

Integration of BIT2 antibody into high-throughput functional genomics requires these methodological strategies:

• Automated Western blotting platforms:

  • Optimize BIT2 antibody for capillary-based automated protein detection systems

  • Develop standardized protocols for consistent detection across numerous samples

  • Establish quantitative calibration curves for normalization between experimental runs

  • Implement internal controls for cross-plate/batch normalization

• Reverse phase protein arrays (RPPA):

  • Spot lysates from mutant yeast libraries onto nitrocellulose-coated slides

  • Probe arrays with BIT2 antibody followed by signal amplification

  • Quantify signal intensity to measure BIT2 levels across genetic perturbations

  • Correlate BIT2 expression patterns with phenotypic data

• High-content screening microscopy:

  • Grow yeast strain libraries in multiwell formats

  • Fix and immunostain with BIT2 antibody and fluorescent secondary antibody

  • Image using automated microscopy platforms

  • Extract quantitative data on expression level, localization, and morphological features

  • Identify genetic factors affecting BIT2 expression or localization

• Integration with CRISPR-based yeast screens:

  • Leverage recent advances in yeast diversifying base editors (yDBE) for targeted mutation

  • Generate diversified BIT2 protein variants using in vivo CRISPR-dCas9-directed cytidine deaminase

  • Screen libraries for altered BIT2 function using the antibody as detection reagent

  • Correlate sequence variations with functional outcomes

What considerations are important when applying BIT2 antibody to study evolutionary conservation across fungal species?

When expanding BIT2 antibody use to evolutionary studies, researchers should consider:

• Sequence homology analysis workflow:

  • Perform bioinformatic analysis to identify BIT2 homologs across fungal species

  • Generate multiple sequence alignments to identify conserved epitope regions

  • Predict cross-reactivity based on epitope conservation percentages

  • Design validation experiments focusing on species with varying degrees of homology

• Cross-reactivity testing methodology:

  • Prepare protein extracts from multiple fungal species

  • Run parallel Western blots with identical conditions

  • Include S. cerevisiae extract as positive control

  • Quantify relative signal intensity across species

  • Correlate signal strength with evolutionary distance or sequence conservation

• Epitope conservation analysis:

  Species	Sequence Identity to S. cerevisiae BIT2	Predicted Cross-Reactivity	Experimental Validation Method
  S. cerevisiae	100%	Strong (positive control)	Western blot, immunofluorescence
  Close relative (e.g., S. paradoxus)	90-95% (hypothetical)	High	Western blot, immunoprecipitation
  Moderate relative (e.g., Candida species)	60-70% (hypothetical)	Moderate	Epitope-specific ELISA, concentrated samples
  Distant relative (e.g., Neurospora crassa)	30-40% (hypothetical)	Low/None	Highly sensitive detection methods

• Functional conservation studies:

  • Compare subcellular localization patterns across species using immunofluorescence

  • Assess conservation of protein-protein interactions through cross-species immunoprecipitation

  • Analyze post-translational modifications across species using 2D gel electrophoresis and Western blotting

  • Evaluate functional complementation between orthologs from different species

How can BIT2 antibody be utilized in single-cell analysis of yeast populations?

For single-cell level analysis using BIT2 antibody, implement these methodological approaches:

• Flow cytometry applications:

  • Develop fixation and permeabilization protocols optimized for yeast cell wall

  • Stain with BIT2 antibody and fluorophore-conjugated secondary antibody

  • Analyze population heterogeneity in BIT2 expression

  • Combine with cell cycle markers to correlate expression with cell cycle stages

  • Sort subpopulations based on BIT2 expression for downstream analysis

• Single-cell immunofluorescence microscopy:

  • Fix yeast cells on microscopy slides or in microfluidic devices

  • Permeabilize and immunostain with BIT2 antibody

  • Counterstain with organelle markers and nuclear dyes

  • Perform quantitative image analysis to measure:

    • Expression level variability within population

    • Subcellular localization patterns

    • Correlation with morphological features

    • Cell-to-cell variation in protein abundance

• Microfluidic device integration:

  • Trap individual yeast cells in microfluidic chambers

  • Perform on-chip immunostaining with BIT2 antibody

  • Monitor protein expression in the same cells over time using fixation time-course

  • Correlate expression patterns with single-cell growth rates or stress responses

• Single-cell proteomics approaches:

  • Isolate single cells through sorting or micromanipulation

  • Perform miniaturized immunoassays for BIT2 detection

  • Correlate with other protein markers measured in the same cells

  • Integrate with single-cell transcriptomics for multi-omics analysis

What approaches can be used to validate BIT2 antibody specificity for critical research applications?

A comprehensive validation strategy for BIT2 antibody includes:

• Genetic validation approaches:

  • Compare antibody reactivity between wild-type and BIT2 knockout yeast strains

  • Test against BIT2 overexpression strains to confirm signal intensity correlation

  • Use epitope-tagged BIT2 constructs to verify co-detection with tag-specific antibodies

  • Implement RNA interference to create reduced expression controls

• Biochemical validation methods:

  • Perform immunodepletion by pre-incubating antibody with recombinant BIT2 protein

  • Analyze immunoprecipitated proteins by mass spectrometry to confirm primary target

  • Conduct peptide competition assays with synthesized epitope peptides

  • Perform epitope mapping using peptide arrays or truncated protein constructs

• Advanced specificity analysis:

  • Implement Western blotting under various denaturing and native conditions

  • Test cross-reactivity against purified related proteins

  • Use immunoprecipitation followed by mass spectrometry for unbiased binding assessment

  • Compare reactivity patterns with orthogonal detection methods

• Validation benchmarks and criteria:

  Validation Test	Expected Result	Interpretation if Failed	Alternative Approach
  Signal in wild-type vs. knockout	Present in WT, absent in KO	Non-specific binding	Epitope-tagging strategy
  Pre-absorption with antigen	Significant signal reduction	Multiple targets or non-specific binding	Affinity purification against recombinant BIT2
  IP-Mass Spec	BIT2 as top hit	Cross-reactivity or non-specific binding	Develop alternative antibody
  Signal correlation with mRNA levels	Positive correlation	Post-transcriptional regulation or non-specific binding	Targeted proteomics approach